Bausch + Lomb Advances Novel Oral Treatment for Dry AMD

Bausch + Lomb Corporation announced progress in the development of BL1243 (tonabersat), an investigational oral treatment for dry age-related macular degeneration (AMD), following a constructive meeting with the FDA.